MedTrace Logo

Clinical Assessment of DAILIES TOTAL1® (DT1) Multifocal

NCT02871375 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2018-07-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate DAILIES TOTAL1® Multifocal (DTl MF) contact lenses in current multifocal contact lens wearers with symptoms of end of day discomfort compared to their habitual multifocal contact lens correction.

Conditions

  • Refractive Error

Interventions

DEVICE

Delefilcon A multifocal contact lenses

Multifocal contact lenses worn in a daily wear, daily disposable modality (new pair of lenses each morning)

DEVICE

Habitual multifocal contact lenses

Multifocal contact lenses worn per subject's habitual prescription and habitual daily wear modality

Sponsors & Collaborators

  • Alcon, a Novartis Company

    lead INDUSTRY

Principal Investigators

  • Clinical Project Manager, PLS · Alcon, A Novartis Division

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-30
Primary Completion
2016-11-14
Completion
2016-11-14

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02871375 on ClinicalTrials.gov